APA (7th ed.) Citation

Ali, M., Hira, A. K., Jawaid, H., Zakaria, F., & Somjee, Z. (2021). Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: A systematic review and meta-analysis. Middle East Fertility Society Journal, 26(1), 1. https://doi.org/10.1186/s43043-021-00064-5

Chicago Style (17th ed.) Citation

Ali, Mustafa, Aruna Kumari Hira, Haris Jawaid, Faiza Zakaria, and Zehra Somjee. "Safety and Efficacy of Elagolix (with and Without Add-back Therapy) for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Leiomyomas: A Systematic Review and Meta-analysis." Middle East Fertility Society Journal 26, no. 1 (2021): 1. https://doi.org/10.1186/s43043-021-00064-5.

MLA (9th ed.) Citation

Ali, Mustafa, et al. "Safety and Efficacy of Elagolix (with and Without Add-back Therapy) for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Leiomyomas: A Systematic Review and Meta-analysis." Middle East Fertility Society Journal, vol. 26, no. 1, 2021, p. 1, https://doi.org/10.1186/s43043-021-00064-5.